CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Bismuth-containing Standard Triple Therapy the First-line Eradication Therapy for Helicobacter pylori
Yeon-Ji Kim, Woo Chul Chung
Korean J Helicobacter  Up Gastrointest Res. 2021;21(4):354-358.   Published online December 8, 2021
DOI: https://doi.org/10.7704/kjhugr.2021.0027

Excel Download

Meta-Analysis: Lactobacillus Containing Quadruple Therapy Versus Standard Triple First-Line Therapy for Helicobacter pylori Eradication
Helicobacter. 2009;14(5):449-459   Crossref logo
Link1 Link2

Bismuth-containing Standard Triple Therapy the First-line Eradication Therapy for Helicobacter pylori
The Korean Journal of Helicobacter and Upper Gastrointestinal Research. 2021;21(4):354-358   Crossref logo
Link1 Link2 Link3

Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication
Alimentary Pharmacology & Therapeutics. 1998;12(3):277-279   Crossref logo
Link1 Link2 Link3

Moxifloxacin-Containing Triple Therapy versus Bismuth-Containing Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis
Helicobacter. 2011;16(2):131-138   Crossref logo
Link1 Link2

Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen
Medical Principles and Practice. 2017;26(6):523-529   Crossref logo
Link1 Link2

Efficacy of bismuth added to standard triple therapy as the first‐line eradication regimen for Helicobacter pylori infection
Helicobacter. 2021;26(3):   Crossref logo
Link1 Link2 Link3

Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study
International Journal of Clinical Practice. 2010;64(11):1530-1534   Crossref logo
Link1 Link2 Link3

Meta-Analysis of Levofloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy as Second-Line Treatment in the Eradication of Helicobacter pylori
Gastroenterology. 2011;140(5):S-880   Crossref logo
Link1 Link2

Su1694 Meta-Analysis of Levofloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy as Second-Line Treatment in the Eradication of Helicobacter pylori
Gastroenterology. 2012;142(5):S-483   Crossref logo
Link1 Link2

First-line Bismuth-containing Five-day Concomitant Quintuple Therapy forHelicobacter PyloriEradication
Helicobacter. 2015;21(2):100-105   Crossref logo
Link1 Link2